[Supplemental and total parenteral nutrition in assisting the very small premature infant].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to G Rizzi.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Age and survival data in a series of 178 patients operated for malignant breast tumour during the period 1957-67 are statistically assessed. The mean survival period was 9 yr. Young subjects had a greater chance of survival, while their mortality rate was the lowest after the fifth year.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The hipopituitarim's treatment is in want to use the hormonal replacement with corticosteroid and l-tiroxine in all patients. The exogenous gonadotropin or sexual hormones are administrated in both sexes in different way for different ages. The pituitary dwarfism secondary to GH deficiency is now cured with the syntetic GH use. The DDAVP is the drug of choice in the therapy of diabetes insipidus.
In 16 patients with high cortisol plasma levels MRI and CT investigation of adrenal gland region was performed; 13 also had the pituitary region examined. CT and MRI results in Cushing's Syndrome due to adrenal glands etiology (8 cases) are overlapping. The morphological criteria utilized consist in the radiological finding of bilateral adrenal hyperplasia or adrenal mass (adenoma, carcinoma). The great amount of retroperitoneal fat increases the normal contrast with both techniques. In the pituitary Cushing's Syndrome MRI was more sensible than CT as far as it concerns ACTH producing pituitary lesion assessment; this technique may show 5 mm diameter adenomas for their high signal intensity.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.